CWP
AURA icon

Concord Wealth Partners’s Aura Biosciences AURA Stock Holding History

Concord Wealth Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-150
Closed -$3K – 1282
2021
Q4 		$3K Buy
+150
New +$2.68K ﹤0.01% 1029

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Concord Wealth Partners's AURA Position: Q1 2022 in Review

Concord Wealth Partners sold out of Aura Biosciences (AURA) in Q1 2022, closing a stake of 150 shares — an estimated $3K sold.

Concord Wealth Partners first reported a position in AURA in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 34 funds tracked by Wall St. Rank hold AURA as of Q1 2022.

  • Concord Wealth Partners reported no remaining Aura Biosciences position as of Q1 2022 after selling out during the quarter.
  • Concord Wealth Partners sold 150 Aura Biosciences shares in Q1 2022, an estimated $3K.
  • Concord Wealth Partners first reported a position in Aura Biosciences in Q4 2021 and held it in 1 quarter.
  • Concord Wealth Partners's Aura Biosciences position peaked at $3K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2022.

Based on Concord Wealth Partners's 13F filing for Q1 2022, filed 20 Apr 2022.